Second Sight Medical Products Statistics Share Statistics Second Sight Medical Products has 50.74M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 50.74M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 31.58M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 1.08M, so 0% of the outstanding
shares have been sold short.
Short Interest 1.08M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 4.42
Valuation Ratios The PE ratio is -5.99 and the forward
PE ratio is null.
Second Sight Medical Products's PEG ratio is
0.1.
PE Ratio -5.99 Forward PE n/a PS Ratio -411.47 Forward PS n/a PB Ratio 0.78 P/FCF Ratio -5.81 PEG Ratio 0.1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Second Sight Medical Products.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 28.64,
with a Debt / Equity ratio of 0.
Current Ratio 28.64 Quick Ratio 28.64 Debt / Equity 0 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage -742.42
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $-8.67K Profits Per Employee $-595.53K Employee Count 15 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 12K Effective Tax Rate -0.13%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 2.56, so Second Sight Medical Products's
price volatility has been higher than the market average.
Beta 2.56 52-Week Price Change n/a 50-Day Moving Average 5.84 200-Day Moving Average n/a Relative Strength Index (RSI) 30.48 Average Volume (20 Days) n/a
Income Statement In the last 12 months, Second Sight Medical Products had revenue of -130K
and earned -8.93M
in profits. Earnings per share was -0.82.
Revenue -130K Gross Profit -130K Operating Income -8.91M Net Income -8.93M EBITDA -8.84M EBIT -8.88M Earnings Per Share (EPS) -0.82
Full Income Statement Balance Sheet The company has 69.59M in cash and 237K in
debt, giving a net cash position of 69.36M.
Cash & Cash Equivalents 69.59M Total Debt 237K Net Cash 69.36M Retained Earnings -328.58M Total Assets 65.65M Working Capital 54.8M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.19M
and capital expenditures -14K, giving a free cash flow of -9.2M.
Operating Cash Flow -9.19M Capital Expenditures -14K Free Cash Flow -9.2M FCF Per Share -0.84
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of 6853.08% and 6871.54%.
Gross Margin 100% Operating Margin 6853.08% Pretax Margin 6862.31% Profit Margin 6871.54% EBITDA Margin 6799.23% EBIT Margin 6853.08% FCF Margin 7078.46%
Dividends & Yields EYES does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for EYES.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 19, 2022. It was a
backward
split with a ratio of 1:3.
Last Split Date Aug 19, 2022 Split Type backward Split Ratio 1:3
Scores Altman Z-Score 42.07 Piotroski F-Score 1
